The industry is worried about the spread of Omikron

By Kim, Jin-Gu | translator Choi HeeYoung

22.02.16 06:00:55

가나다라 0

Hyangnam Complex and Osong Complex are confirmed one after another. Quarantine measures for the department for a week

Concerned about production disruptions due to a shortage of replacement personnel…"It's hard to meet the due date

The Omicron mutation COVID-19 virus is also hurting factories and research institutes of pharmaceutical bio companies. Concerns are growing over production disruptions as a series of confirmed cases have emerged in Hwaseong Hyangnam Pharmaceutical Industrial Complex and Cheongju Osong Life Science Complex, where pharmaceutical factories are concentrated.

According to the pharmaceutical industry on the 15th, a series of COVID-19 confirmed cases have recently occurred in the Hyangnam Pharmaceutical Industrial Complex located in Hyangnam-eup, Hwaseong-si, Gyeonggi-do. It is reported that the number of confirmed cases is increasing after the Lunar New Year holiday. Currently, 40 factories of 38 pharmaceuti

Kim, Jin-Gu(kjg@dailypharm.com)

If you want to see the full article, please JOIN US (click)